Rivercell is a Paris-based biotechnology and AI company building the data engine for an AI world model of the cell. Its proprietary platform generates interventional, time-resolved, multimodal single-cell data on how human cells respond to drugs and genetic changes, which trains the AI Virtual Cell model that predicts cellular responses in silico to reduce the need for physical wet-lab experiments in drug discovery. Founded in 2025 by CEO Yann Fleureau (co-founder of Cardiologs, acquired by Philips in 2021) and CSO Eric Durand (former Chief Data Science Officer at Owkin and Bioptimus co-founder), the company runs an automated wet lab in Paris and is backed by HV, HCVC, Alven and Bpifrance Digital Venture.
1
Round
1
Industry
4
Tags
Oct 7, 2026
Latest raise
Funding activity · 1 round
Oct 7, 2026
$25M
Seed
Led by HV Capital
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
